Author:
Williams Gabrielle J.,Hong Angela M.,Thompson John F.
Funder
Melanoma Institute Australia
Reference57 articles.
1. Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy;Ahmed;Ann. Oncol.,2016
2. Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis;Amaral;Immunotherapy,2019
3. Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients;Amaral;J. Immunother. Cancer,2020
4. Malignant melanoma and central nervous system metastases. Incidence, diagnosis, treatment and survival;Amer;Cancer,1978
5. Australia, M.I., Anti-PD-1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) . 2017.